![]() In your initial consultation, prior to the test being ordered, we stronglyĪdvise that you discuss what you would do Your healthcare provider will discuss the report with you and let you know if any other investigations are recommended. Results will be sent to your healthcare provider in 5 business days. Indicate whether there is a low or high probability of the condition being present. Then, for each condition included on the request form, the report will Your sample is checked to see if there is sufficient DNA from the developing pregnancy to provide a reliable result. What the NIPT report will include, and how you will receive your test results ![]() If a particular proportion is too high or too low, this indicates that there may be a chromosome condition involving the placenta and, potentially, the developing baby. ![]() The assay analyses the proportions of the DNA fragments that come from specific TDL Genetics uses an NIPT assay called Veriseq v2, manufactured by Illumina and processed in our London laboratory. There are small fragments of DNA in the mother’s blood that have come from both the mother and the placenta. Patients who have received bone marrow or organ transplants, or those who have metastatic cancer are not eligible for the test. You must be at least 10 weeks pregnant for this test. Although the chance of having a baby with Down syndrome increases withĪge, most babies with Down syndrome are born to women under 35.2 ![]() It is not as accurate as the screening for trisomy 21, 18 and 13.Ĭhromosomal conditions like Down syndrome (trisomy 21) do not typically run in families and can happen in any pregnancy. Screening for other syndromes or for fetal sex is reasonably reliable however, NIPT screening for trisomy 21, 18 and 13 – the most common chromosome conditions – provides the highest accuracy. This has reduced the need for invasive tests such as chorionic villus sampling (CVS) or amniocentesis, although these will still be required to confirm a high It is much more accurate than first trimester blood Non-invasive prenatal testing (NIPT) is a screening test – it is a test for women who are unlikely to have a baby with a chromosome condition. If you're fromĭulwich or the surrounding area, and you are looking for a reliable, trustworthy clinic for your prenatal screening, contact us today. Typically, the Illumina test results are available in less than 7 working days. The Illumina test is far more accurate than traditional screening and offers lower false positive rates.Īt Women’s Health Dulwich, we work closely with the UK’s oldest and largest private laboratory. This is a much-preferred option than traditional, stressful invasive testing such as chorionic villous sampling (CVS) and amniocentesis.Ĭhromosomal conditions can occur in any pregnancy, and our Illumina tests are able to provide you with peace of mind about the health of your baby and its likelihood of developing the most commonĬhromosomal conditions. Mother, which is taken from 10 weeks gestation. All that is required is a blood sample from the The Illumina test has been clinically proven to have detection rates of over 99% for Down's Syndrome, and can be performed at no risk to the baby. The screening involves a simple blood test taken from the mother during pregnancy (from 10 weeks onwards) which strongly predicts some of the most commonĬhromosomal abnormalities such as Trisomy 21 (Down's Syndrome), Trisomy 18 (Edwards Syndrome), Trisomy 13 (Patau Syndrome). We are one of few centres in the UK now offering the Illumina testįor screening for Down's Syndrome. The Illumina Test is a non-invasive prenatal screening test (NIPT), to determine the risk of Down’s Syndrome in an unborn child.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |